JP2001509784A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509784A5
JP2001509784A5 JP1997541225A JP54122597A JP2001509784A5 JP 2001509784 A5 JP2001509784 A5 JP 2001509784A5 JP 1997541225 A JP1997541225 A JP 1997541225A JP 54122597 A JP54122597 A JP 54122597A JP 2001509784 A5 JP2001509784 A5 JP 2001509784A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997541225A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001509784A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/009094 external-priority patent/WO1997043451A1/en
Publication of JP2001509784A publication Critical patent/JP2001509784A/ja
Publication of JP2001509784A5 publication Critical patent/JP2001509784A5/ja
Ceased legal-status Critical Current

Links

JP54122597A 1996-05-15 1997-05-15 非ヌクレオチド連結試薬 Ceased JP2001509784A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64782096A 1996-05-15 1996-05-15
US08/647,820 1996-05-15
PCT/US1997/009094 WO1997043451A1 (en) 1996-05-15 1997-05-15 Non-nucleotide linking reagents

Publications (2)

Publication Number Publication Date
JP2001509784A JP2001509784A (ja) 2001-07-24
JP2001509784A5 true JP2001509784A5 (enExample) 2005-01-13

Family

ID=24598396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54122597A Ceased JP2001509784A (ja) 1996-05-15 1997-05-15 非ヌクレオチド連結試薬

Country Status (8)

Country Link
US (1) US6130323A (enExample)
EP (1) EP0954606B1 (enExample)
JP (1) JP2001509784A (enExample)
AT (1) ATE252158T1 (enExample)
AU (1) AU733647B2 (enExample)
CA (1) CA2253969A1 (enExample)
DE (1) DE69725611T2 (enExample)
WO (1) WO1997043451A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1052510B2 (en) * 1998-11-06 2018-08-01 LSI Medience Corporation Novel complexes containing crosslinked avidin, process for preparing and analytical method using the same
DE60121342T2 (de) 2000-08-11 2007-06-28 Idaho Technology, Inc., Salt Lake City Einfach markierte oligonukleotidsonden
US7560231B2 (en) * 2002-12-20 2009-07-14 Roche Molecular Systems, Inc. Mannitol and glucitol derivatives
WO2004089295A2 (en) * 2003-04-01 2004-10-21 Chromagen, Inc. Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
CA2463719A1 (en) 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
EP1502958A1 (en) * 2003-08-01 2005-02-02 Roche Diagnostics GmbH New detection format for hot start real time polymerase chain reaction
EP1700922B1 (en) 2005-03-10 2016-08-24 Roche Diagnostics GmbH 3-Substituted 5-Nitroindole derivatives and labeled oligonucleotide probes containing them
EP1801114B8 (de) 2005-11-23 2009-12-02 Roche Diagnostics GmbH Polynukleotid mit Phosphatmimetikum
JP4713514B2 (ja) * 2006-02-20 2011-06-29 エフ.ホフマン−ラ ロシュ アーゲー 改善された標識試薬
EP2156370B1 (en) 2007-05-14 2011-10-12 Historx, Inc. Compartment segregation by pixel characterization using image data clustering
EP2162728B1 (en) 2007-06-15 2016-07-27 Novartis AG Microscope system and method for obtaining standardized sample data
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
WO2009029810A1 (en) 2007-08-31 2009-03-05 Historx, Inc. Automatic exposure time selection for imaging tissue
WO2010033508A1 (en) 2008-09-16 2010-03-25 Historx, Inc. Reproducible quantification of biomarker expression
MX2012003396A (es) 2009-09-16 2012-04-10 Genentech Inc Complejos de proteina conteniendo helice super-enrollada y/o enlazador tether y usos de los mismos.
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
CN103384825B (zh) 2010-12-23 2017-05-24 霍夫曼-拉罗奇有限公司 通过二价结合剂检测经翻译后修饰的多肽
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
CN104105711B (zh) 2012-02-10 2018-11-30 弗·哈夫曼-拉罗切有限公司 单链抗体及其他异多聚体
EP2867253B1 (en) 2012-06-27 2016-09-14 F. Hoffmann-La Roche AG Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
MX2014014804A (es) 2012-06-27 2015-02-12 Hoffmann La Roche Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo.
CN107001482B (zh) 2014-12-03 2021-06-15 豪夫迈·罗氏有限公司 多特异性抗体
EP3484908A4 (en) * 2016-07-15 2020-04-08 AM Chemicals Llc NON-NUCLEOSIDIC SOLID CARRIERS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTID SYNTHESIS
CN108219513B (zh) * 2018-03-14 2019-11-08 青岛科技大学 一种羧基荧光素的制备方法

Similar Documents

Publication Publication Date Title
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000500055A5 (enExample)
JP2000508849A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2001521681A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2001502813A5 (enExample)
JP2000502714A5 (enExample)
JP2000500184A5 (enExample)